| Recruiting | Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer NCT07407647 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Recruiting | The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and NCT07285044 | Mayo Clinic | Phase 2 |
| Not Yet Recruiting | Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. NCT07267780 | National Cancer Institute, Naples | — |
| Recruiting | Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) NCT07281430 | National Cancer Institute (NCI) | N/A |
| Recruiting | Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer NCT06804135 | Tata Memorial Hospital | — |
| Enrolling By Invitation | Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening NCT07186530 | Mayo Clinic | N/A |
| Not Yet Recruiting | Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in NCT07088731 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Not Yet Recruiting | Transmission of Oncogenic HPV Infection Among Families NCT07036211 | Tampere University Hospital | — |
| Recruiting | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog NCT07118176 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations NCT07038369 | Atavistik Bio, Inc | Phase 1 |
| Recruiting | Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961 | Institut Claudius Regaud | N/A |
| Active Not Recruiting | Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) NCT06611553 | National Cancer Institute (NCI) | N/A |
| Active Not Recruiting | Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) NCT06611540 | National Cancer Institute (NCI) | N/A |
| Recruiting | HPV Vaccine, Imiquimod, and Metformin Combination Trial NCT06686043 | Baylor College of Medicine | Phase 2 |
| Recruiting | Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients Wit NCT06492070 | Emory University | Phase 2 |
| Recruiting | Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) NCT06498661 | National Cancer Institute (NCI) | N/A |
| Terminated | Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experi NCT06752135 | Azienda Policlinico Umberto I | — |
| Recruiting | Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical NCT06241235 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Phase 1 / Phase 2 |
| Recruiting | Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast NCT06800612 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | The Ohio State University (OSU) SCREEN Community Program NCT06666192 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Adaptive Radiotherapy in Patients With Gynecological Tumors NCT06230549 | University Hospital, Essen | N/A |
| Recruiting | PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer NCT05581121 | Institut Claudius Regaud | Phase 3 |
| Active Not Recruiting | Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Can NCT05824468 | Sun Yat-sen University | Phase 2 |
| Completed | Barriers to Cervical Cancer Screening NCT06284447 | Mayo Clinic | — |
| Completed | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors NCT05795595 | CRISPR Therapeutics AG | Phase 1 / Phase 2 |
| Completed | Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trau NCT05458869 | OHSU Knight Cancer Institute | — |
| Terminated | HPV16 E6 TCR T Cells for Cervical Carcinoma NCT05357027 | TCRCure Biopharma Ltd. | Phase 1 / Phase 2 |
| Suspended | A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers NCT05337735 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies NCT05032040 | Xencor, Inc. | Phase 2 |
| Recruiting | A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478 | Suzhou BlueHorse Therapeutics Co., Ltd. | Phase 1 |
| Completed | Gynecological Sentinel Lymph Nodes CEUS NCT05105087 | Thomas Jefferson University | EARLY_Phase 1 |
| Unknown | PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer NCT05311566 | Lei Li | Phase 2 |
| Unknown | Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical Cancer NCT05087264 | Fifth Affiliated Hospital, Sun Yat-Sen University | EARLY_Phase 1 |
| Unknown | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Cl NCT05180851 | Shanghai Fengxian District Central Hospital | EARLY_Phase 1 |
| Active Not Recruiting | Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer NCT05139368 | University of Utah | N/A |
| Completed | Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalach NCT04411849 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | Clinical Validation of Molecular Triage in HR-HPV Positive Women NCT05193669 | Hiantis Srl | — |
| Active Not Recruiting | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Express NCT04802876 | SOLTI Breast Cancer Research Group | Phase 2 |
| Completed | Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results NCT04821297 | Thomas Jefferson University | N/A |
| Active Not Recruiting | Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiatio NCT04713618 | Ohio State University Comprehensive Cancer Center | — |
| Recruiting | Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer NCT04567771 | Mayo Clinic | N/A |
| Terminated | Pembrolizumab and Olaparib in Cervical Cancer Patients NCT04483544 | Baptist Health South Florida | Phase 2 |
| Completed | Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization NCT04208724 | Fred Hutchinson Cancer Center | N/A |
| Active Not Recruiting | I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination NCT04452526 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers NCT04459273 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Unknown | Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme? NCT03975127 | NHS Greater Glasgow and Clyde | N/A |
| Terminated | A Study of LY3435151 in Participants With Solid Tumors NCT04099277 | Eli Lilly and Company | Phase 1 |
| Unknown | Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma NCT04443296 | Sun Yat-sen University | Phase 1 |
| Completed | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tum NCT03849469 | Xencor, Inc. | Phase 1 |
| Completed | A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) NCT03752398 | Xencor, Inc. | Phase 1 |
| Terminated | Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Canc NCT03345784 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivo NCT03372720 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Fractional CO2 Laser Therapy for Survivors of Breast Malignancies NCT03307044 | Ohio State University Comprehensive Cancer Center | N/A |
| Withdrawn | Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High NCT03220009 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinom NCT03108495 | Iovance Biotherapeutics, Inc. | Phase 2 |
| Completed | Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer NCT03180294 | NRG Oncology | Phase 2 |
| Completed | Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma NCT03086681 | Yong Zhang,MD | Phase 2 |
| Completed | Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors NCT02835833 | University of Alabama at Birmingham | Phase 1 |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) NCT02628067 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or NCT02584478 | Advenchen Laboratories, LLC | Phase 3 |
| Completed | HPV Self-Test Intervention in Ohio Appalachia NCT02460237 | Ohio State University Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and The NCT02412124 | City of Hope Medical Center | N/A |
| Completed | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma NCT02523365 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Completed | Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malig NCT02578888 | Albert Einstein College of Medicine | N/A |
| Completed | Can Text Reminders Improve Uptake of Cervical Screening? NCT02363088 | Sarah Huf | N/A |
| Recruiting | Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening NCT04927650 | University of California, San Francisco | — |
| Completed | CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community He NCT02355262 | OHSU Knight Cancer Institute | — |
| Completed | Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies NCT02025985 | Karyopharm Therapeutics Inc | Phase 2 |
| Completed | Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening NCT01550783 | University of Washington | N/A |
| Completed | Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcin NCT01554410 | University of California, San Diego | Phase 1 |
| Active Not Recruiting | Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 NCT00867464 | National Cancer Institute (NCI) | — |
| Completed | Cervical Cancer Screening Intervention Among Korean American Women NCT02594826 | Fox Chase Cancer Center | N/A |
| Terminated | Ixabepilone to Treat Cervical Cancer NCT00924066 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer NCT00791635 | M.D. Anderson Cancer Center | — |
| Completed | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced C NCT00423254 | Mannkind Corporation | Phase 1 |
| Completed | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia NCT00081263 | Gynecologic Oncology Group | Phase 2 |
| Completed | Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma NCT00595725 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Prognostic Value of Protein IMP3 Expression in Cervical Cancer NCT05151159 | University of Mostar | — |
| Completed | Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance NCT00026663 | National Cancer Institute (NCI) | — |